CXT
Crane NXT, Co.
CXT has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over CXT overall, supported by stronger modeled upside and stronger valuation.
CXT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Under pressure |
CXT's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CXT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $56.99 | — |
| Cheap | 15x | $32.96 | -42% |
| Fair | 19x | $41.21 | -28% |
| Current | 26x | $56.99 | — |
| Expensive | 27x | $60.07 | +5.4% |
Historical ranges are pointers, not guarantees.
CXT's PE is in its expensive range at 26x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CXT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CXT, but weaker profitability. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CXT on the outlook, with more favorable profitability expectations.
CXT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | +108% |
| Q3 2026 | $2.20 | -18% |
| Q2 2026 | $2.41 | -8% |
| Q1 2026 | $2.23 | -23% |
| Q4 2025 | $2.50 | -22% |
| Q3 2025 | $2.68 | -12% |
| Q2 2025 | $2.62 | -17% |
| Q1 2025 | $2.91 | -8.2% |
| Q4 2022 | $2.43 | -4.7% |
CXT has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CXT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $497.1M | +12% |
| Q2 2026 | $493.2M | +22% |
| Q1 2026 | $387.7M | +17% |
| Q4 2025 | $476.9M | +19% |
| Q3 2025 | $445.1M | +10% |
| Q2 2025 | $404.4M | +9.1% |
| Q1 2025 | $330.3M | +5.3% |
| Q4 2024 | $399.1M | +12% |
CXT's revenue has grown year over year for 10 quarters in a row: $497M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -5.2 points |
| Q2 2026 | 14% | +2.1 points |
| Q1 2026 | 5.7% | -5.6 points |
| Q4 2025 | 17% | -1 points |
| Q3 2025 | 18% | -0.2 points |
| Q2 2025 | 12% | -6.4 points |
| Q1 2025 | 11% | -6.4 points |
| Q4 2024 | 18% | -2.6 points |
CXT has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CXT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CXT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $90.2M | +15% |
| Q2 2026 | $73.4M | +32% |
| Q1 2026 | -$24.1M | +$8.1M |
| Q4 2025 | $96M | +37% |
| Q3 2025 | $78.7M | +47% |
| Q2 2025 | $55.8M | +16% |
| Q1 2025 | -$32.2M | -$29.2M |
| Q4 2024 | $70.3M | +11% |
CXT has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CXT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.2% | +100K shares |
| 3 years | +1% | +600K shares |
| 5 years | -66% | -113M shares |
| Available history | -67% | -116M shares |
CXT has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
| Q2 2021 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CXT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.7x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.7x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CXT's net debt is about 3.0 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CXT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.5 | Neutral |
| Stochastic | 73.0 | Neutral |
CXT's weekly RSI is 61 (neutral) and its Stochastic is 73 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CXT PE vs Industrials Sector
| Metric | CXT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 24x | 7.6% above |
| PE % | 82 | 58 | 24 pts above |
CXT is trading at 26x earnings, in line with the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CXT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.0 | 5.6% above |
| 20 week MA | $52.2 | 9.2% above |
| 50 week MA | $48.8 | 17% above |
| 100 week MA | $53.1 | 7.3% above |
| 200 week MA | $54.1 | 5.4% above |
CXT has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CXT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.0 | $26.7 | -11% |
| 2021 | $26.7 | $34.6 | +30% |
| 2022 | $34.6 | $34.6 | -0.2% |
| 2023 | $34.6 | $56.9 | +65% |
| 2024 | $56.9 | $58.0 | +2% |
| 2025 | $58.0 | $48.4 | -17% |
| 2026 YTD | $48.4 | $57.0 | +18% |
CXT has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.